US Patent Issued to California Institute of Technology, The Regents of the University of California, 1200 Pharma on Dec. 2 for "CDK inhibitors and uses thereof" (California Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,280, issued on Dec. 2, was assigned to California Institute of Technology (Pasadena, Calif.), The Regents of the University of California (Oakland, Calif.) and 1200 Pharma LLC (Culver City, Calif.).

"CDK inhibitors and uses thereof" was invented by Brendan M. O'Boyle (Monrovia, Calif.), Justin A. Hilf (Los Angeles), Scott C. Virgil (Pasadena, Calif.), Alexander W. Sun (Irvine, Calif.), Brian M. Stoltz (San Marino, Calif.), Dylan Conklin (Woodland Hills, Calif.), Martina S. McDermott (Los Angeles), Neil A. O'Brien (Los Angeles), Michael J. Palazzolo (Los Angeles), Dennis Slamon (Woodland Hills, Calif.) and Michael D. Bartberger (Sherman Oaks, Calif.).

According to the abstract* rel...